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Abstract
Genome-wide association studies have revealed an association between coronary heart
disease (CHD) and genetic variation on chromosome 13q34, with the lead single nucleotide
polymorphism rs4773144 residing in the COL4A2 gene in this genomic region. We investi-
gated the functional effects of this genetic variant. Analyses of primary cultures of vascular
smooth muscle cells (SMCs) and endothelial cells (ECs) from different individuals showed a
difference between rs4773144 genotypes in COL4A2 and COL4A1 expression levels,
being lowest in the G/G genotype, intermediate in A/G and highest in A/A. Chromatin immu-
noprecipitation followed by allelic imbalance assays of primary cultures of SMCs and ECs
that were of the A/G genotype revealed that the G allele had lower transcriptional activity
than the A allele. Electrophoretic mobility shift assays and luciferase reporter gene assays
showed that a short DNA sequence encompassing the rs4773144 site interacted with a
nuclear protein, with lower efficiency for the G allele, and that the G allele sequence had
lower activity in driving reporter gene expression. Analyses of cultured SMCs from different
individuals demonstrated that cells of the G/G genotype had higher apoptosis rates. Immu-
nohistochemical and histological examinations of ex vivo atherosclerotic coronary arteries
from different individuals disclosed that atherosclerotic plaques with the G/G genotype had
lower collagen IV abundance and thinner fibrous cap, a hallmark of unstable, rupture-prone
plaques. A study of a cohort of patients with angiographically documented coronary artery
disease showed that patients of the G/G genotype had higher rates of myocardial infarction,
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a phenotype often caused by plaque rupture. These results indicate that the CHD-related
genetic variant at the COL4A2 locus affects COL4A2/COL4A1 expression, SMC survival,
and atherosclerotic plaque stability, providing a mechanistic explanation for the association
between the genetic variant and CHD risk.
Author Summary
People who carry certain variants in their DNA are genetically predisposed to suffer from
coronary heart disease (CHD) caused by abnormal tissue buildup (known as atherosclero-
sis) and blood clotting in the blood vessels of the heart. One of the DNA variants reported
to increase CHD risk is named single nucleotide polymorphism rs4773144. It is still
unclear as to why this DNA variant has an effect on CHD risk. In this study, by studying
blood vessel cells from many people, we found that the DNA variant affects the production
of two collagen genes and vascular cell survival. By examining atherosclerotic tissues from
many patients, we discovered that the atherosclerotic tissues of patients who carry the
rs4773144 variant are structurally more likely to break down and cause blood clotting
which can lead to a heart attack. Furthermore, by studying a group of CHD patients, we
noticed that those who carry the rs4773144 variant do have higher rates of heart attack.
These findings are useful for understanding why this DNA variant has an impact on CHD
risk and suggest that preserving adequate production of these two collagen genes may
reduce the risk of heart attack in CHD patients, a potential strategy for development of
therapeutics for the disease.
Introduction
Coronary heart disease (CHD) is a multifactorial disorder caused by both genetic and life-style
factors. Genome-wide association studies (GWASs) have revealed a relationship between the
disease and genetic variation on chromosome 13q34 [1, 2]. The lead CHD-associated single-
nucleotide-polymorphism (SNP) in this genomic region was rs4773144 located in the third
intron of the COL4A2 gene, with the G allele of this SNP associating with increased CHD risk
[1, 2]. The molecular and cellular mechanisms underlying this genetic association have, how-
ever, remained unclear. Further investigations into such mechanisms are required.
The COL4A1 and COL4A2 genes reside next to each other in the head-to-head orientation
on chromosome 13q34 and share common transcriptional regulatory sequences [3–9]. These
two genes encode the collagen IV protein α1 and α2 chains, respectively [3–9]. Collagen IV is
the major constituent of the basement membrane and is essential for its integrity and function-
ality [10]. In the blood vessel wall, the basement membrane underlies the endothelium and sur-
rounds smooth muscle cells (SMCs) [11]. The basement membrane not only serves as an
extracellular scaffold but also regulates cell behavior [10, 12]. Abnormalities of vascular endo-
thelial cells (ECs) and SMCs play important roles in the pathogenesis of atherosclerosis, the
vascular pathology underlying CHD [13].
In this study, we sought to investigate the functional effects of the CHD-associated SNP
rs4773144 and found that it has an impact on COL4A2/COL4A1 expression, vascular SMC sur-
vival, and coronary atherosclerotic plaque stability.
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Results and Discussion
Effect of SNP rs4773144 genotype on COL4A2 and COL4A1 expression
To investigate if SNP rs4773144 genotype had an effect on COL4A2 and COL4A1 expression,
we carried out quantitative RT-PCR assays using total RNA samples extracted from primary
cultures of vascular SMCs and ECs from different individuals (n = 148 and n = 137, respec-
tively). The assays showed a genotypic effect of rs4773144 on COL4A2 RNA levels in both cell
types, with the G allele associating with lower expression level in an additive fashion (Fig 1A
and 1B), and a similar effect on COL4A1 RNA levels (Fig 1C and 1D).
The above results suggest that rs4773144 per se, or a SNP in linkage disequilibrium with it,
influences COL4A2 and COL4A1 expression. The COL4A1 and COL4A2 genes, situated on
chromosome 13q34, are in a head-to-head arrangement, being separated by a bidirectional
promoter that drives the transcription of COL4A1 and COL4A2 in opposite directions [3–6].
Studies have shown that transcription of these two genes is modulated by regulatory sequences
located in the first intron of each gene and the third intron of COL4A2 [5, 7–9]. SNP rs4773144
resides in the third intron of COL4A2, and is in strong linkage disequilibrium (r2>0.8) with
3 other SNPs (rs4773143, rs7986871 and rs3809346) which are also located in intron 3 of
COL4A2. A bioinformatics analysis showed that these SNPs reside in a genomic region that has
Fig 1. Influence of SNP rs4773144 genotype onCOL4A2 andCOL4A1 expression levels. Primary cultures of
vascular SMCs and ECs from different individuals were genotyped for rs4773144 and subjected to quantitative
reverse transcriptase–polymerase chain reaction analysis ofCOL4A2 andCOL4A1. Showed in the graphs are
relative fold differences in COL4A2 (A andB) andCOL4A1 (C andD) RNA levels in SMCs (A andC) and ECs (B and
D), respectively. Columns and error bars represent mean and SEM values; p-values shown are for an additive genetic
model.
doi:10.1371/journal.pgen.1006127.g001
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important transcriptional regulatory features including H3k27Ac marks and DNase I hyper-
sensitivity, identified by the ENCODE and Roadmap Epigenomics project (S1 Fig and S2 Fig).
Therefore, we investigated whether SNP rs4773144 affects gene transcription. To this end,
we carried out chromatin immunoprecipitation to capture transcriptionally active chromatins
using an antibody against RNA polymerase II (Pol II) and then performed allelic imbalance
analyses of the immunoprecipitated chromatins from cells that were heterozygous for
rs4773144. The analyses showed that in both SMCs and ECs, the ratio of the rs4773144 G allele
versus the A allele was lower in chromatin samples precipitated by the anti-Pol II antibody
than in non-precipitated chromatin samples (Fig 2A and 2B), indicating that the G allele has
lower transcriptional activity than the A allele. An analogous analysis using an anti-H3k27Ac
antibody showed a similar trend (S3 Fig).
To further test if the DNA sequence at the rs4773144 site can modulate gene transcription,
we performed a luciferase reporter gene assay. In this experiment, SMCs were transfected with
a firefly luciferase gene plasmid containing either the rs4773144 G or A allele sequence as well
as a renilla luciferase gene plasmid to serve as a transfection efficiency reference. The experi-
ment showed that G allele plasmid transfectants had lower firefly luciferase levels than A allele
plasmid transfectants (Fig 3A), suggesting that the G allele sequence had lower activity in driv-
ing gene transcription.
Fig 2. Influence of SNP rs4773144 genotype on gene transcription. Primary cultures of vascular SMCs (A) and ECs
(B) of the A/G genotype for SNP rs4773144 from different individuals were subjected to chromatin immunoprecipitation
using an antibody against Pol II, followed by an allelic imbalance analysis of SNP rs4773144, with the use of the
TaqMan method to determine the ratio of Ct value of the A allele (detected by a VIC fluorescein-labeled probe) versus
the Ct value of the G allele (detected by a FAM fluorescent dye-labeled probe). Upper panels show amplification curves
of the A allele (red) and G allele (green). Column charts in the lower panels show the relative fold difference in G to A
ratio of Ct values between input DNA and anti-Pol II antibody precipitated chromatin DNA. Columns and error bars
represent mean and SEM values.
doi:10.1371/journal.pgen.1006127.g002
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Further experiments using the electrophoretic mobility shift assay technique showed bind-
ing of a nuclear protein to oligonucleotide probes corresponding to the DNA sequence at the
rs4773144 site, with lower binding efficiency for the G allele [the DNA-protein complex band
had a higher intensity in assays with labeled A allele probe (lane 2) than in assays with labeled
G allele probe (lane 9), and was reduced more readily by unlabeled A allele probe (lane 4) than
by unlabeled G allele probe (lane 6)](Fig 3B). A bioinformatics analysis showed that the DNA
sequence at the rs4773144 site (TTCACGGGA[A/G]) shared similarity with the consensus
binding element (TTCNNNNGAA) of the transcription factor STAT3 (S4 Fig). To investigate
if the protein in the DNA-protein complex mentioned above was STAT3, we performed elec-
trophoretic mobility super-shift assay using an anti-phospho-STAT3 antibody; however, the
formation and mobility of the DNA-protein complex mentioned above was unaffected by the
antibody (S5 Fig), suggesting that it may involve a different protein.
Effect of SNP rs4773144 genotype on cell behavior
Collagen IV is the major constituent of the basement membrane and participates in cell-matrix
and cell-cell communication [14]. Studies have suggested that collagen IV binds to integrins
and activates integrin-mediated intracellular signaling, consequently promoting endothelial
cell proliferation and inhibiting apoptosis [15–19]. Integrins promote cell survival and inhibit
apoptosis, in part by up-regulating the expression of the anti-apoptotic protein BCL2 [20, 21].
In agreement, we found that knockdown of either COL4A2 or COL4A1 in SMCs and ECs
resulted in increased apoptosis with a decrease of BCL2 (S6–S9 Figs). Importantly, an analysis
of primary cultures of SMCs from different individuals showed an influence of rs4773144 on
the rate of apoptosis, with the G allele associating with higher apoptotic rates (Fig 4A). Simi-
larly, there was an association between the G allele and lower levels of the anti-apoptotic pro-
tein BCL2 in primary cultures of ECs from different individuals (Fig 4B).
Fig 3. Effect of SNP rs4773144 on transcriptionmodulating activity of a DNA sequence encompassing the SNP and on nuclear
protein interaction with the DNA sequence. (A) Vascular SMCs were transfected with a firefly luciferase reporter gene plasmid
(pGL3-promoter vector) with an insert corresponding to a DNA sequence encompassing the rs4773144 site of the A or G allele, or with the
empty plasmid (control), together with a plasmid (pRL-TK) containing a renilla luciferase gene to serve as a transfection efficiency reference.
At 48 hour after transfection, activities of firefly luciferase and renilla luciferase were measured. Columns and error bars represent mean and
SEM values of the ratio of firefly luciferase activity to renilla luciferase activity. (B) A representative image of electrophoretic mobility shift
assays. Nuclear protein extracts from vascular ECs were incubated with biotin-labeled probes corresponding to the A allele (lanes 1–7) or
the G allele (lanes 8–14) of SNP rs4773144 in the absence or presence of competitors in 20-fold or 50-fold molar excess, as indicated
underneath the image.
doi:10.1371/journal.pgen.1006127.g003
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Effect of SNP rs4773144 genotype on collagen IV levels in
atherosclerotic plaques and on plaque stability
Further to the assays of primary cultures of vascular cells described above, we investigated if
there was a relationship between rs4773144 genotype and collagen IV levels in atherosclerotic
plaques. In this investigation, atherosclerotic coronary arteries from different individuals were
genotyped for rs4773144 and subjected to immunohistochemical analyses using antibodies
against COL4A2 and the smooth muscle cell marker SMA (smooth muscle alpha-actin),
respectively. The analyses showed a genotypic effect of rs4773144 on the percentages of
COL4A2 positive areas in atherosclerotic plaques, with the G allele associating with lower per-
centages (Fig 5A and 5B).
It is well established that an atherosclerotic plaque typically contains a lipid core covered by
a fibrous cap which is primarily composed of SMCs and extracellular matrix proteins [22].
SMC apoptosis can reduce the SMC content and the thickness of the fibrous cap, rendering
the plaque prone to rupture, which can trigger thrombosis [23, 24]. Coronary thrombosis is
the most common cause of acute coronary ischemic events such as myocardial infarction (MI)
[25, 26].
Since our experiments described earlier showed that rs4773144 genotype influenced SMC
apoptosis, we investigated whether rs4773144 genotype had an effect on atherosclerotic plaque
cap thickness. Histopathological examination of atherosclerotic coronary arteries from individ-
uals of different genotypes for rs4773144 showed a genotypic effect of rs4773144 in plaque cap
thickness, with the G allele associating with thinner plaque cap and lower cap/intima ratio (Fig
5C and 5D, S10 Fig and S11 Fig).
Since atherosclerotic plaques with a thin cap are unstable and prone to rupture [23, 24] and
coronary atherosclerotic plaque is the primary cause of MI [25, 26], we investigated if there
was an association between rs4773144 and MI in CHD patients. We studied a group of patients
with angiographically documented coronary disease with>50% luminal stenosis, and observed
a genotypic effect of rs4773144, with the G allele associating with higher rates of MI, which
remained after adjusting for age, sex, low-density-lipoprotein cholesterol, hypertension, and
diabetes mellitus (Table 1).
Fig 4. Influence of SNP rs4773144 genotype on apoptosis. (A) Primary cultures of SMCs from different individuals were genotyped
for rs4773144 and subjected to apoptosis assay. Shown in the graph are relative differences in cell apoptotic rate in different genotype
groups. Columns and error bars represent mean and SEM values; p-values shown are for an additive genetic model. (B) Primary
cultures of ECs of different genotypes for rs4773144 were subjected to immunoblot analysis of the anti-apoptotic protein BCL2. Shown
on the left are representative immunoblot images and on the right a graphic presentation of BCL2 band intensities standardized against
band intensities of the loading control HSC70. Columns and error bars represent mean and SEM values; p-values shown are for an
additive genetic model.
doi:10.1371/journal.pgen.1006127.g004
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Summary
There are several novel findings from this study on the effect of the CHD-associated SNP
rs4773144 located in the COL4A2 gene. At the molecular and cellular levels, a genotypic effect
on COL4A2 and COL4A1 expression in vascular ECs and SMCs and on cell survival was
detected. From the examination of ex vivo coronary atherosclerotic plaques, we found a
Fig 5. Association of SNP rs4773144 with collagen IV level in atherosclerotic plaques and plaque cap
thickness. Atherosclerotic coronary arteries from different individuals were genotyped for SNP rs4773144 and
subjected to histopathological analyses using Image-Pro software. (A) A representative image of immunostaining,
blue color indicates COL4A2 staining, and brown smooth muscle alpha-actin. ×400 original magnification. (B)
Percentages of COL4A2 immunostain positive areas in atherosclerotic plaques in different genotype groups. (C)
Atherosclerotic plaque cap thickness in different genotype groups. (D) Atherosclerotic plaque cap/intima ratios in
different genotype groups. Columns and error bars inB-D are mean and SEM values; p-values shown are for an
additive genetic model.
doi:10.1371/journal.pgen.1006127.g005
Table 1. Association between SNP rs4773144 andMI incidence/prevalence in CHD patients.
MI Non-MI odds ratio (95% CI), p-value odds ratio* (95% CI), p-value
n (%) n (%)
A/A genotype 70 (30.8%) 163 (38.1%) reference reference
A/G genotype 106 (46.7%) 206 (48.1%) 1.20 (0.83–1.73), p = 0.332 1.20 (0.82–1.76), p = 0.356
G/G genotype 51 (22.5%) 59 (13.8%) 2.01 (1.26–3.21), p = 0.003 2.09 (1.28–3.41), p = 0.003
frequency frequency
A allele 0.54 0.62 reference
G allele 0.46 0.38 1.39 (1.10–1.75), p = 0.005
*adjusted for age, sex, low-density-lipoprotein cholesterol, hypertension, and diabetes mellitus.
MI, myocardial infarction; CI, confidence interval.
doi:10.1371/journal.pgen.1006127.t001
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relationship between the CHD risk genotype and histological features of plaque instability. Fur-
thermore, in the study of patients with angiographically documented CHD, we observed an
association between the risk allele and occurrence of MI. These findings provide a mechanistic
explanation for the association between CHD risk and genetic variation at the COL4A1/
COL4A2 locus.
Each collagen IV molecule is composed of three α chains forming a triple helical structure,
with the classic isoform containing two α1(IV) chains and one α2(IV) chain [27]. The COL4A1
and COL4A2 genes, which encode the α1(IV) and α2(IV) chains respectively, reside next to
each other on chromosome 13q34 and are transcriptionally co-regulated [3–9]. Severe rare
mutations in either COL4A1 or COL4A2 have been reported to cause vascular lesions and hem-
orrhagic stroke in humans [14, 28–31], suggesting that defects of either α1(IV) or α2(IV) can
result in similar vascular phenotypes. In agreement, our study shows that SNP rs4773144 geno-
type affects the expression of both COL4A1 and COL4A2, and the siRNA experiments demon-
strate that knockdown of either COL4A1 or COL4A2 in vascular SMCs or ECs induces cell
apoptosis (which is line with a reported finding that a frame shift mutation in the COL4A2
gene increases rates of apoptosis of fibroblasts isolated from an individual carrying the muta-
tion [31]). Apart from providing a mechanistic explanation for the association between
rs4773144 and CHD, these results suggest that preserving adequate production of both of these
two collagen IV genes can be a potential strategy for developing new therapeutics for the
disease.
Data from the ENCODE and Roadmap Epigenomics projects show DNase I hypersensitiv-
ity and histone modifications surrounding rs4773144 in a number of different types of cells
and tissues including SMCs, ECs, monocytes, T-cells, B-cells, adipose, heart, skeletal muscle,
brain, thymus, etc. It is possible that rs4773144 genotype may affect COL4A2/COL4A1 expres-
sion not only in vascular SMCs and ECs as demonstrated in this study but also in other cells,
and that additional functional mechanisms involving other tissues may also contribute to the
association between rs4773144 and CHD.
Over 50 genomic loci have hitherto been identified by GWASs to be associated with CHD
risk [32]. However, for many of these loci, the functional mechanisms leading to the genetic
effect remain unknown. Functional characterization of these genetic variants can aid the
understanding of the underlying biological mechanisms and may facilitate the translation of
the genetic discoveries to therapeutic development. The findings of our present study on the
CHD-related genetic variant at the COL4A1/COL4A2 locus are pertinent in this context.
Materials and Methods
Ethics statement
NRES Committee London–City & East (approval number: 08/H0704/140) and Shantou Uni-
versity Medical College Ethics Committee approved this research.
Isolation, culture and analyses of primary vascular SMCs and ECs
SMCs were isolated from arteries of umbilical cords from different individuals; ECs were iso-
lated from umbilical cord veins. Isolated SMCs and ECs were subjected to immunocytochemi-
cal examinations of the SMC marker SMA, the EC marker vonWillebrand factor (vWF), and
the fibroblast marker discoidin domain receptor-2 (DDR2), which verified that SMCs were
SMA-positive but vWF- and DDR2-negative and that ECs were vWF-positive but SMA- and
DDR2-negative. Primary cultures of SMCs and ECs, up to passage 5, were used in experiments
of this study.
Functional Effects ofCOL4A1/COL4A2Gene Variant
PLOS Genetics | DOI:10.1371/journal.pgen.1006127 July 7, 2016 8 / 15
Determination of genotypes
Genomic DNA was extracted from cultured SMCs and ECs or from sections of formaldehyde-
fixed paraffin-embedded blocks of atherosclerotic coronary arteries using the Wizard SV
Genomic DNA Purification System (Promega). rs4773144 genotypes were determined with the
use of the TaqMan SNP genotyping assay. Accuracy of the genotyping results was verified by
sequencing of a random selection of the samples.
Quantitative reverse transcriptase–polymerase chain reaction
Total RNA samples were prepared from primary cultures of SMCs and ECs, with the use of the
SV Total RNA Isolation System (Promega). RNA was reverse transcribed into cDNA using
random primers (Promega) and M-MLV reverse transcriptase (Promega). The resultant cDNA
was subjected to real-time polymerase chain reactions for COL4A1, COL4A2, and β-actin,
respectively, with the use of TaqMan Gene Expression Assays. The 2-ΔΔCT method [33] was
used to ascertain differences between genotypes in COL4A1 and COL4A2 levels standardized
against the reference gene β-actin.
Chromatin immunoprecipitation and allelic imbalance assays
SMCs and ECs, heterozygous for SNP rs4773144, were crosslinked by incubation in formalde-
hyde and then incubated with glycine to quench formaldehyde. Subsequently, cells were lysed
and chromatin sheared to 200–1,000bp in length by sonication. Aliquots of the samples were
incubated with protein G-agarose beads and then further with an anti-human RNA polymerase
II antibody (Santa Cruz Biotechnology, sc-9001). DNA-protein-antibody complexes bound to
protein G-agarose beads were precipitated by centrifugation and de-crosslinked. Sheared chro-
matin samples and immunoprecipitated DNA samples were subjected to allelic imbalance
analyses of SNP rs4773144, with the use of the TaqMan method to determine the Ct values for
the A allele (detected by a VIC fluorescein-labeled probe) and G allele (detected by a FAM fluo-
rescent dye-labeled probe), respectively. Additionally, heterozygous ECs were subjected to
chromatin immunoprecipitation using an anti-human H3k27Ac antibody (Abcam ab4729)
and then TaqMan assay to determine the G allele versus A allele ratio.
Luciferase reporter gene assays
A 350 base pair DNA sequence encompassing the rs4773144 site of the A and G alleles, respec-
tively, was amplified by PCR and inserted into the pGL3-promoter vector (Promega) contain-
ing a firefly luciferase reporter gene. The resultant construct containing the inserted DNA
sequence corresponding to either the A or G allele of rs4773144 was mixed with a plasmid
(pRL-TK, Promega) containing a renilla luciferase gene and transfected into cultured vascular
SMCs. At 48 hours after transfection, the transfectants were lysed, and the activities of firefly
luciferase and renilla luciferase in the lysates were measured. The ratio of firefly luciferase activ-
ity to renilla luciferase activity was used as a measurement of the transcription modulating
activity of the inserted DNA sequence encompassing the rs4773144 site of the A and G alleles,
respectively.
Electrophoretic mobility shift assays
Biotin-labelled, double-stranded 25-mer oligonucleotides corresponding to the sequences at
and surrounding the SNP rs4773144 site were used as probes. The probe sequences were: 5'-C
CTTTCACGGGAACTGGGAACTTAA-3' (A allele) and 5’-CCTTTCACGGGAGCTGGGAA
CTTAA-3’ (G allele), respectively. The probes were individually incubated with nuclear
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extracts of cultured ECs, in the presence or absence of unlabelled oligonucleotide competitors
in molar excess or an anti-phospho-STAT3 antibody (Cell Signaling Technology, #9131), fol-
lowed by non-denaturing polyacrylamide gel electrophoresis. Free probes and probe-protein
complexes were detected using a LightShift Chemiluminescent EMSA kit (Pierce Biotechnol-
ogy, 20148). Three independent experiments were carried out.
COL4A2 or COL4A1 siRNA knockdown
SMCs and ECs were transfected with either COL4A2 siRNA (ThermoFisher Scientific,
4457308), COL4A1 siRNA (ThermoFisher Scientific, AM16708), or control siRNA (Thermo-
Fisher Scientific, 4390843), with the use of Lipofectamine RNAiMAX transfection reagent
(Invitrogen, 13778150). COL4A2 or COL4A1 knockdown was verified by immunoblotting
analysis.
Immunoblotting analyses
Cell lysates were prepared by incubating cells with a lysis buffer containing a protease inhibitor
cocktail. An aliquot of 20μg proteins from each sample was subjected to Tris-glycine, sodium-
dodecyl-sulfate, polyacrylamide gel electrophoresis, followed by standard immunoblotting
analysis with an anti-COL4A2 antibody (Abcam, ab69782), an anti-COL4A1 antibody
(Abnova, PAB17326), an anti-BCL2 antibody (Abcam, ab32124), an anti-β-actin antibody, or
an anti-HSC70 antibody (Santa Cruz, sc7298).
Cell accumulation and apoptosis assays
SMCs (same number) or ECs (same number) transfected with either the COL4A2 siRNA,
COL4A1 siRNA or control siRNA, or untransfected primary SMCs (same number) from differ-
ent individuals, were cultured for 72 hours, and then detached and counted. Additionally, cells
were subjected to apoptosis assays with the use of Annexin V-FITC apoptosis detection kit
(Beyotime Institute of Biotechnology, C1062, for transfected cells) or Cell Death Detection
ELISAPLUS kit (Roche, 11774425001, for untransfected cells) to quantify histone-complexed
DNA fragments.
Immunohistochemical analysis of ex vivo coronary artery atherosclerotic
plaques
Formaldehyde-fixed paraffin-embedded sections of atherosclerotic coronary arteries from
autopsies were deparaffinised, rehydrated, and incubated in sodium citrate for antigen
retrieval. The sections were subjected to peroxidase immunostaining with a mouse anti-human
smooth muscle α-actin (SMA) antibody (Dako, M-0635). A subset of the collection was sub-
jected to peroxidase/alkaline phosphatase double immunostaining with the mouse anti-human
smooth muscle α-actin (SMA) antibody (Dako, M-0635) and a rabbit anti-human COL4A2
antibody (Abcam, ab69782). Chromagens were diaminobenzidine and nitrobluetetrazolium/
bromo-chloro-indolyl phosphate, respectively. Images of the sections were captured using a
microscope with an imaging system and analyzed using Image-Pro software to determine the
sizes of positive immunostain areas, atherosclerotic plaque cap thickness, and intima thickness.
Patients with angiographically documented coronary artery disease
We studied 1125 consecutive patients undergoing diagnostic or interventional coronary angi-
ography in the First Affiliated Hospital of Shantou University Medical College. All subjects
were Chinese. We collected demographic and clinical data including age, sex, plasma levels of
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total cholesterol, low-density-lipoprotein cholesterol, high-density lipoprotein cholesterol and
triglycerides, coronary angiographic findings, incident or prevalent MI diagnosed according to
the World Health Organization criteria, systolic and diastolic blood pressure, and the presence
or absence of diabetes mellitus. Of the 1125 subjects, 655 had significant angiographically doc-
umented CHD as having>50% diameter stenosis in1 major epicardial coronary artery.
Among them, a total of 227 subjects had incident or prevalent MI. The study was approved by
the appropriate research ethics committee. The data were analyzed anonymously.
Statistical analyses
Variables not in normal distribution were normalized by logarithmic transformation. Linear
regression analyses were performed to test differences between genotypes in COL4A1 and
COL4A2 expression levels, apoptosis assay result, BCL2 immunoblotting band intensity (stan-
dardized against HSC70 band intensity), percentage of COL4A2 stain areas in total atheroscle-
rotic plaque area, atherosclerotic plaque cap thickness, and atherosclerotic plaque cap/intima
ratio, in an additive genetic model. Student’s t-tests were used to ascertain allelic differences in
the allelic expression imbalance assays and the chromatin immunoprecipitation assays. Stu-
dent’s t-tests were also used to test differences between cells transfected with either the
rs4773144 A allele plasmid or G allele plasmid in firefly luciferase activity after standardized
against renilla luciferase activity in the luciferase assays, and between cells transfected with
COL4A2 siRNA or COL4A1 siRNA and cells transfected with control siRNA in cell count, pro-
liferation assay result, apoptosis assay result, and BCL2 immunoblotting band intensity (stan-
dardized against β-actin band intensity), respectively. Logistic regression analyses and chi-
squared tests were carried out to ascertain genotypic and allelic association with MI in CHD
patients. All p values were two-sided.
Supporting Information
S1 Fig. Results of bioinformatics analysis of SNP rs4773144: Data from the ENCODE proj-
ect. A bioinformatics analysis with the use of the UCSC Genome Browser showed that SNP
rs4773144, and 3 other SNPs (rs4773143, rs7986871 and rs3809346) in strong linkage disequi-
librium (r2>0.8) with it, are located in a genomic region that has important transcriptional reg-
ulatory features including DNase I hypersensitivity and H3k27Ac marks, identified by the
ENCODE project.
(PDF)
S2 Fig. Results of bioinformatics analysis of SNP rs4773144: Data from the Roadmap Epi-
genomics Project. Data from the Roadmap Epigenomics Project show that SNP rs4773144
(position indicated by vertical yellow line) and 3 other SNPs (rs4773143, rs7986871 and
rs3809346) in strong linkage disequilibrium (r2>0.8) with it, are located in a genomic region
that has important transcriptional regulatory features including DNase I hypersensitivity and
H3k27Ac marks in a large number of cell lines and tissues of different types.
(PDF)
S3 Fig. Results of chromatin immunoprecipitation analysis with anti-H3K27Ac antibody.
Primary cultures of vascular ECs of the A/G genotype for SNP rs4773144 were subjected to
chromatin immunoprecipitation using an antibody against H3K27Ac, followed by an allelic
imbalance analysis of SNP rs4773144 by TaqMan assay. Data shown are mean (SEM) values of
G allele to A allele ratio in input DNA and anti-H3K27Ac antibody precipitated chromatin
DNA.
(PDF)
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S4 Fig. Results of bioinformatics analysis of SNP rs4773144: Data from RegulomeDB. Data
from RegulomeDB show that SNP rs4773144 (position indicated by vertical red line) and 3
other SNPs (rs4773143, rs7986871 and rs3809346) in strong linkage disequilibrium (r2>0.8)
with it, are located in a genomic region with binding of the RNA polymerase II POLR2A sub-
unit and transcription factors, detected by the ENCODE project, and that the DNA sequence
at the rs4773144 site shares similarity with the consensus binding element of the transcription
factor STAT3.
(PDF)
S5 Fig. Formation and mobility of the DNA-protein complex unaffected by anti-STAT3
antibody. A representative image of electrophoretic mobility shift assay. Nuclear protein
extracts were prepared from vascular ECs that had been stimulated with interleukin-6 (200ng/
mL) and interleukin-6 soluble receptor (200ng/mL) for 20 hours. Nuclear protein extracts were
incubated with a biotin-labeled probe corresponding to the A allele of SNP rs4773144 in the
absence or presence of an anti-phospho-STAT3 antibody (Cell Signaling Technology, Cat. No.
#9131) or competitors in 50-fold molar excess, as indicated underneath the image.
(PDF)
S6 Fig. Effect of COL4A2 knockdown on cultured vascular SMCs.Human aortic artery
SMCs were transfected with COL4A2 siRNA or control siRNA. (A) Transfected cells were sub-
jected to immunoblotting analysis of the target protein COL4A2 and the housekeeping protein
β-actin. Shown in figure are representative immunoblotting images. (B) Transfected cells
(same number) were cultured on collagen IV coated or uncoated multi-well plates for 72
hours, and then detached and counted. Column chart shows mean and SEM values of cell
counts from four independent experiments. (C) Transfected cells were subjected to immuno-
blotting analysis of the anti-apoptotic protein BCL2 and the housekeeping protein β-actin.
Upper panel shows representative immunoblotting images. Column chart shows mean and
SEM values of BCL2 band intensity standardized against β-actin band intensity from three
independent experiments. (D) Transfected cells were cultured on collagen IV coated or
uncoated multi-well plates, and subjected to apoptosis assays. Images show representative
staining results: nuclei of apoptotic cells are in green, and those in non-apoptotic cells are in
blue. Column chart shows mean and SEM values of apoptotic cells from four independent
experiments.
(PDF)
S7 Fig. Effect of COL4A2 knockdown on cultured vascular ECs. Cultured ECs were trans-
fected with COL4A2 siRNA or control siRNA. (A) Transfected cells were subjected to immuno-
blotting analysis of the target protein COL4A2 and the housekeeping protein β-actin. Shown in
figure are representative immunoblotting images. (B) Transfected cells (same number) were
cultured on collagen IV coated or uncoated multi-well plates for 72 hours, and then detached
and counted. Column chart shows mean and SEM values of cell counts from four independent
experiments. (C) Transfected cells were subjected to immunoblotting analysis of the anti-apo-
ptotic protein BCL2 and the housekeeping protein β-actin. Upper panel shows representative
immunoblotting images. Column chart shows mean and SEM values of BCL2 band intensity
standardized against β-actin band intensity from three independent experiments. (D) Trans-
fected cells were cultured on collagen IV coated or uncoated multi-well plates, and subjected to
apoptosis assays. Images show representative staining results: nuclei of apoptotic cells are in
green, and those in non-apoptotic cells are in blue. Column chart shows mean and SEM values
of apoptotic cells from four independent experiments.
(PDF)
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S8 Fig. Effect of COL4A1 knockdown on cultured vascular SMCs.Human aortic artery
SMCs were transfected with COL4A1 siRNA or control siRNA. (A) Transfected cells were sub-
jected to immunoblotting analysis of the target protein COL4A1 and the housekeeping protein
β-actin. Shown in figure are representative immunoblotting images. (B) Transfected cells
(same number) were cultured on collagen IV coated or uncoated multi-well plates for 72
hours, and then detached and counted. Column chart shows mean and SEM values of cell
counts from four independent experiments. (C) Transfected cells were subjected to immuno-
blotting analysis of the anti-apoptotic protein BCL2 and the housekeeping protein β-actin.
Upper panel shows representative immunoblotting images. Column chart shows mean and
SEM values of BCL2 band intensity standardized against β-actin band intensity from three
independent experiments. (D) Transfected cells were cultured on collagen IV coated or
uncoated multi-well plates, and subjected to apoptosis assays. Images show representative
staining results: nuclei of apoptotic cells are in green, and those in non-apoptotic cells are in
blue. Column chart shows mean and SEM values of apoptotic cells from four independent
experiments.
(PDF)
S9 Fig. Effect of COL4A1 knockdown on cultured vascular ECs. Cultured ECs were trans-
fected with COL4A1 siRNA or control siRNA. (A) Transfected cells were subjected to immuno-
blotting analysis of the target protein COL4A1 and the housekeeping protein β-actin. Shown in
figure are representative immunoblotting images. (B) Transfected cells (same number) were
cultured on collagen IV coated or uncoated multi-well plates for 72 hours, and then detached
and counted. Column chart shows mean and SEM values of cell counts from four independent
experiments. (C) Transfected cells were subjected to immunoblotting analysis of the anti-apo-
ptotic protein BCL2 and the housekeeping protein β-actin. Upper panel shows representative
immunoblotting images. Column chart shows mean and SEM values of BCL2 band intensity
standardized against β-actin band intensity from three independent experiments. (D) Trans-
fected cells were cultured on collagen IV coated or uncoated multi-well plates, and subjected to
apoptosis assays. Images show representative staining results: nuclei of apoptotic cells are in
green, and those in non-apoptotic cells are in blue. Column chart shows mean and SEM values
of apoptotic cells from four independent experiments.
(PDF)
S10 Fig. Association of SNP rs4773144 with plaque cap thickness. Atherosclerotic coronary
arteries from different individuals were genotyped for SNP rs4773144 and subjected to histo-
pathological analysis. Atherosclerotic plaque cap thickness was analyzed using Image-Pro soft-
ware. (A) Data from sample set one; (B) Data from sample set two; (C) Results from the two
sample sets combined. Data shown are mean and SEM values in different genotype groups; p-
values shown are for an additive genetic model.
(PDF)
S11 Fig. Association of SNP rs4773144 with plaque cap/intima thickness ratio. Atheroscle-
rotic coronary arteries from different individuals were genotyped for SNP rs4773144 and sub-
jected to histopathological analysis. Atherosclerotic plaque cap thickness and whole intima
thickness were analyzed using Image-Pro software. (A) Data from sample set one. (B) Data
from sample set two. (C) Results from the two sample sets combined. Data shown are mean
and SEM values in different genotype groups; p-values shown are for an additive genetic
model.
(PDF)
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